FDA Permits Marketing of Artificial Intelligence-Based Device to Detect Certain Diabetes

FDA permits marketing of artificial intelligence-based device to detect certain diabetes

The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.

Source: fda.gov